Introduction
Th e United States Government is committed to supporting the establishment and sustainability of comprehensive global disease surveillance. Many agencies across the U.S. Government, working in a coordinated fashion in every region of the world, are engaged in this essential mission. Th is commitment is based on the recognition that a weakness in the surveillance system in one part of the world is a weakness for the entire globe, and that every nation needs the infrastructure to prepare for, respond to, and recover from health emergencies. Th is work is also in support of Article 44 of the Revised International Health Regulations [IHR (2005) ], which directs countries that are able to provide assistance to other nations through technical cooperation and fi nancial resources to develop, strengthen and maintain core disease surveillance capacities [1] .
Several U.S. Government agencies have been engaged in eff orts to support global disease surveillance for years, and in some cases, for decades. Agencies work together to coordinate eff orts, ensure sustainable programs, and address the needs of partner countries. In this paper, we present an overview of each individual agency, their particular interests and strengths, and the focus of their operations. Th is overview is intended to help the international community better understand the U.S. Government partner agencies, how they operate, and how they diff er from their partners.
U.S. Government agencies engaged in supporting global disease surveillance
Th e following section provides a brief overview of each U.S. Government agency. Agencies are presented in alphabetical order.
U.S. Agency for International Development Emerging Pandemic Threats Program
Th e U.S. Agency for International Development (USAID) launched the Emerging Pandemic Th reats (EPT) program [2] to aggressively preempt or combat diseases that could spark future pandemics by emphasizing early identi fi cation of, and response to, dangerous pathogens in animals before they can become signifi cant threats to human health. Using a risk-based approach, the EPT program builds on USAID's experience in disease surveillance, training, and outbreak response to focus on geographic areas where these threats are most likely to emerge. Th e EPT program draws on expertise from across the animaland human-health sectors to build regional, national, and local capacities for early disease detection, laboratorybased disease diagnosis, rapid disease response and containment, and risk reduction. Th ese eff orts target a limited number of geographic areas, known as "hot spots, " where new disease threats have emerged in the past. Th e EPT program focuses on "hot spots" in the Congo Basin of East and Central Africa, the Mekong region and other "hot spots" in Southeast Asia, the Amazon region of South America, and the Gangetic Plain of South Asia.
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USAID anticipates that the EPT program will develop predictive models for early identifi cation of viral and other biological threats in "hot spot" regions and that it will enhance regional, national, and local capacities for surveillance, laboratory diagnosis, and fi eld epidemiology in both the animal-and human-health sectors in these areas. Th e EPT program's investments in disease detection and response will be refl ected in their routine application in the management of more normative diseases in these areas, such as malaria, cholera, and meningitis. Th ese contributions more broadly support the tenets outlined in the IHR(2005) and equivalent international health standards of the World Organization for Animal Health (OIE).
U.S. Department of Agriculture
Agricultural Research Service
Th e Agricultural Research Service (ARS) [3] is the principal in-house research agency of the U.S. Department of Agriculture (USDA). ARS is actively engaged in implementing research programs that support global disease surveillance initiatives for plants and animals, including emerging diseases and zoonotic agents that pose a threat to human health. ARS research pro grams support disease surveillance initiatives in several U.S. Government agencies, such as USDA's Animal and Plant Health Inspection Service (APHIS), the Centers for Disease Control and Prevention (CDC), and the State Department's Biosecurity Engagement Program (BEP). In addition, ARS actively collaborates with international part ners worldwide on research projects dedicated to support disease surveillance programs. ARS is one of the founding members of the Global Foot-and-Mouth Disease Research Alliance (GFRA), which has as its primary mission to support the United Nations' Food and Agricultural Organization (FAO) and OIE global eff orts to control and eradicate Foot-and-Mouth Disease (FMD).
Animal and Plant Health Inspection Service
USDA's Animal and Plant Health Inspection Service (APHIS) [4] plays a signifi cant role in increasing global food security by promoting technology-and science-based solutions and capacity-building activities in countries around the world. A cornerstone of this concept is enhanced coordination between the agricul ture and public health sectors for disease surveillance, detection, and control. APHIS plays a direct role in public health, especially in eff orts to mitigate veterinary diseases and ensure the healthfulness of agricultural practices and products. APHIS has programs in disease detection and surveillance, disease exclusion, animal disease infor ma tion systems, and emergency response. Technical exper tise is delivered through APHIS's Centers for Epidemiology and Animal Health, the National Surveillance Unit, the National Veterinary Services Laboratory and the National Animal Health Laboratory Network.
U.S. Department of Defense Armed Forces Health Surveillance Center, Division of Global Emerging Infection Surveillance and Response
Th e Division of Global Emerging Infections Surveillance and Response (GEIS) of the Armed Forces Health Surveillance Center (AFHSC) [5] coordinates a global program of infectious disease surveillance under the fi ve militarily relevant pillars of respiratory infections, gastrointestinal infections, antimicrobial resistant organisms, febrile and vector-borne infections, and sexually transmitted infections. In addition to surveil lance activities, capacity building, training, and commu ni cation are important dimensions to the program. Currently, GEIS operates projects in over 80 countries through out the world, and Department of Defense overseas laboratories perform the majority of the work outside the U.S. from their fi xed assets in Cairo, Egypt; Nairobi, Kenya; Bangkok, Th ailand; Lima, Peru; and Southeast Asia.
GEIS releases requests for proposals, evaluated through a competitive proposal review process, with emphasis on identifi ed gap areas. Recent emphases are on standardization, expanded military-to-military engagements, and fusion of surveillance activities into those of the host nations, thus enhancing capacity building eff orts. Compliance with IHR(2005) provides the framework for these eff orts, while fostering open, professional, and supportive relationships between U.S. Government and host country public health assets.
Chemical and Biological Defense Program
Th e Chemical and Biological Defense Program, [6] 
. CBEP works with a number of partner countries to assist in compliance with the IHR(2005), the OIE reporting guidelines, and the FAO reporting guide lines. CBEP also works with partner countries to imple ment a disease surveillance, detection, diagnosis, report ing, and response system that is safe, secure, and sustainable; and to integrate existing surveillance eff orts to improve global disease surveillance and ensure timely, accurate situational awareness of infectious disease threats.
U.S. Department of Energy Los Alamos National Laboratory
Los Alamos National Laboratory (LANL) [8] is a premier national security research institution under the Department of Energy (DOE), delivering scientifi c and engineering solutions for crucial and complex problems. A broad multi-agency research and development program is pursued at LANL in support of global infectious disease surveillance. Th ese eff orts include the development and application of enabling information science and technology, high throughput bioanalytical systems, characterization of host-pathogen interactions, and fi eld deployable detection and identifi cation systems.
Th e Department of Energy Joint Genome Institute, of which LANL is a principal component, is a major national microbial genome sequencing resource that has completed over 30 percent of the bacterial genomes sequenced nationwide. Th e High Th roughput Laboratory Network (HTLN) is a joint eff ort with the University of California Los Angeles, and is designed to process and analyze hundreds of samples per day in order to support global surveillance of infectious diseases of both health and security concern and to establish a global network for information/data management, sharing and knowledge generation. High performance computing resources support immune and epidemiological modeling and pathogen feature recognition and pathogen signature detection assay design. Th rough its many collaborations, LANL strives to develop effi cacious cost-eff ective surveillance technologies and an enabling knowledge base to achieve a sustainable global infectious disease surveillance network.
U.S. Department of Health and Human Services
Th e Department of Health and Human Services (HHS) is the technical agency for human health, disease surveillance, and the public health response to emer gen cies and disasters. Th e IHR(2005) Program sits in Th e Offi ce of the Assistant Secretary for Preparedness and Response (ASPR) within HHS, [9] and works closely with the offi cial National Focal Point for the United States-the Operations Center for the Offi ce of the Secretary of HHS. Th e Centers for Disease Control and Prevention (CDC) -programs described below-is part of HHS.
Centers for Disease Control and Prevention
Global Disease Detection Program
Th e Global Disease Detection program in the Division of Global Disease Detection and Emergency Response [10] is CDC's principal program for developing and strengthen ing global public health capacity to rapidly identify and contain naturally occurring or man-made disease threats from around the world. Th e program presently comprises eight international regional centers and CDC headquarters components. Th e GDD regional centers, located in every WHO region of the world, work with country partners to implement disease detection and response trainings, protocols, and interventions. Th e centers' expertise includes training in fi eld epidemiology and laboratory methods, surveillance and response for emerging infectious disease threats, assistance with pandemic infl uenza preparedness, promotion of zoonotic disease investigations and control eff orts, risk communi cations, and laboratory biosafety and improved labora tory systems. A cadre of US-based CDC scientists provides technical expertise to the regional centers. In recognition of GDD's capacity development activities, WHO designated GDD as a Collaborating Center for Implementation of IHR National Surveillance and Response Capacity in December 2009. An integral part of GDD is the GDD Operations Center located at CDC headquarters. Th is innovative epidemic intelligence and response operations unit uses nontraditional surveillance methods and information from internationally-based CDC staff and partners to provide early warning about international disease threats thereby positioning CDC to respond rapidly when assistance is requested. CDC is a key partner in Global Outbreak Alert Response Network (GOARN) and participation of CDC staff in GOARN teams is coordinated by the GDD Operations Center. 
Division of Public Health Systems and Workforce Development
U.S. Department of State
Biosecurity Engagement Program
Th e U.S. Department of State manages America's relationships with foreign governments, international organizations, and the people of other countries. Th e Biosecurity Engagement Program (BEP) [12] seeks to engage biological scientists and combat biological threats worldwide by providing assistance to improve biosecurity and biosafety, conduct cooperative research, and improve infectious disease detection and surveillance. Specifi cally, BEP provides assistance in: biosafety and biosecurity, through technical consultations, risk assessments, and training courses that build human capacity and internal expertise to create a sustainable culture of laboratory biorisk management; disease detection and control, by strengthen ing the capacity for public health and veterinary health systems to detect, report, and control infectious disease outbreaks; scientist engagement, by encouraging a safe, secure and sustainable bioscience capacity through joint scientifi c collaborations designed to help prevent, detect, and respond to biological threats; and sustainable capacity, with a focus on long-term sustainability and capacity build ing that creates an infrastructure for biorisk management.
BEP leverages technical resources and experts from numerous U.S. agencies, universities, international organi za tions, NGOs, and the National Academies of Sciences to meet its core objectives. In addition to interagency and organizational collaborations, BEP works closely with host-country governments, U.S. Embassies, and other nations to identify needs and implement assistance necessary to ensure safe, secure, and sustainable bioscience capacity, while achieving the larger goal of reducing global biological risks. BEP eff orts are threat-driven and designed to prevent, detect, and respond to both existing and emerging global biological threats.
Discussion
Eff ective global engagement in support of disease surveillance capacity building requires coordination and partnership. Each of the above-mentioned agencies and offi ces has unique resources and technical expertise. Th ese entities fi rst must coordinate with each other and then with international partners to ensure that global engagement eff orts are effi cient, build off of each other's expertise, and are best combined to promote eff ective disease surveillance capacity building. Th is internal coordi nation is not without challenges, as each entity has diff erent organizational cultures, administrative processes, and substantive expertise. Agencies do, however, actively try to work around these challenges, and use the White House National Security Staff as an overarching coordinating body.
In addition to internal U.S. coordination, agencies require a strong working relationship with partner countries in order to be most eff ective. Ideal country engagement involves a commitment on the part of the partner country to an agreed upon strategy for engagement that includes planning for fi nancial sustain ability and human resources needs. Eff ective engagement also requires the designation of points of contact for coordinating eff orts, and a commitment to open communication with the assisting entity. Additionally, it requires that both the U.S. and its partner country recognize that their individual perception of needs and priorities may diff er, and that strong relationships and communications are essential to successful engagement.
Conclusion
Th e U.S. is committed to providing resources and expertise to enhance global disease surveillance and assist in building a comprehensive, eff ective and effi cient public health infrastructure. Each U.S. Government agency that is engaged in building global disease surveillance capacity brings its own particular expertise and interest to the endeavor. Th ese agencies, however, work closely in coordi nation both with other U.S. entities as well as with partner countries and organizations, building on individual expertise.
